ForumIAS LATEST
- SFG FRC 2027 | Program starts from 15th Dec. 2026 | Admissions open for Tranche-1 Entrance Test till 25th Oct. 2026 Click Here to know more →
- Prelims Test Series (PTS) for Prelims 2027 starts 11th Oct. 2026 Click Here to know more →
- [Pre-order] Ethics Redbook 3rd Edition: Delivery starts from 21st October onwards Click Here to Read More →
- 21 Sept. | GS Advance Program (GSAP) for UPSC 2027 Mains starts from 11th Oct. Click Here to Read More →
News: United States Food and Drug Administration(FDA) has approved SalivaDirect test for Covid19.
Facts:
- Who developed the test? The SalivaDirect test has been developed by researchers from Yale School of Public Health in partnership with the National Basketball Association(NBA).
- How is the test different? SalivaDirect test uses saliva samples as opposed to the more invasive nasopharyngeal swabs.
- What is the testing Procedure? The collection and testing of saliva samples involves three steps — collecting saliva without preservative buffers, proteinase K treatment and heat inactivation and dualplex RT-qPCR virus detection.
- Significance:
- The testing can detect the virus even when the number of virus copies in the saliva sample is as low as 6-12 copies per microlitre.
- The test is affordable when compared to other tests of Covid-19.
- The testing makes sample collection non-invasive and reduces the need for trained healthcare workers to collect the samples, reducing the risk of infection during collection.
- This test is more accurate when compared to tests using nasopharyngeal swabs which sometimes leads to false negative results due to errors at the time of sample collection.
